Clinical Trial

Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection

Study acronym: PROCEED-CRC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 29, 2025 (before its estimated July 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The PROCEED-CRC study will prospectively collect blood samples from participants who are at average risk of colorectal cancer (CRC). Samples will be used for research use and the development of a blood-based CRC screening test.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-27.
Trial Details
NCT Number NCT06620627
Lead Sponsor Natera, Inc.
Conditions Colorectal Cancer Screening
Enrollment 5,000 participants
Start Date 2024-01-26
Primary Completion 2025-07-31 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-29